| Literature DB >> 8166320 |
R P Liberman1, T Van Putten, B D Marshall, J Mintz, L Bowen, T G Kuehnel, M Aravagiri, S R Marder.
Abstract
Thirteen treatment-refractory schizophrenic patients (10 men and three women) who were receiving more than 50 mg/day of haloperidol and who had been hospitalized for more than 1 year successfully tolerated a mean dose reduction of 63% with consequent improvement in psychopathology and side effects. The addition of intensive behavior therapy to the optimal dose of haloperidol yielded further improvements in functional behavior, such as self-care and social interaction.Entities:
Mesh：
Substances：
Year: 1994 PMID： 8166320 DOI： 10.1176/ajp.151.5.756
Source DB: PubMed Journal: Am J Psychiatry ISSN： 0002-953X Impact factor: 18.112